Neuenhahn, M
Albrecht, J
Odendahl, M
Schlott, F
Dössinger, G
Schiemann, M
Lakshmipathi, S
Martin, K
Bunjes, D
Harsdorf, S
Weissinger, E M
Menzel, H
Verbeek, M
Uharek, L
Kröger, N
Wagner, E
Kobbe, G
Schroeder, T
Schmitt, M
Held, G
Herr, W
Germeroth, L
Bonig, H
Tonn, T
Einsele, H
Busch, D H
Grigoleit, G U
Article History
Received: 3 September 2016
Revised: 20 December 2016
Accepted: 30 December 2016
First Online: 16 January 2017
Competing interests
: LG is an employee of and holds shares in Stage Cell Therapeutics, Göttingen, Germany; now Juno Therapeutics GmbH, Munich, Germany. DHB invented the Streptamer technology and holds shares of Juno Cell Therapeutics Inc. The other authors declare no conflict of interest.